Century Therapeutics (IPSC) EBT (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly EBT of -$90.9 million for Q1 2026, down 218.75% year-over-year from $76.6 million in Q1 2025, and down 852.26% quarter-over-quarter from -$9.5 million in Q4 2025.
Century Therapeutics (IPSC) EBT (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported EBT for 7 consecutive years, with -$90.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 218.75% year-over-year to -$90.9 million; the TTM figure through Mar 2026 stood at -$167.4 million (down 730.63% YoY), while the FY2025 annual figure was $44000.0, up 100.04% from the prior year.
- EBT eased to -$90.9 million in Q1 2026 per IPSC's latest filing, from -$9.5 million in the prior quarter.
- Across five years, EBT topped out at $76.6 million in Q1 2025 and bottomed at -$90.9 million in Q1 2026.
- Historically, EBT has averaged -$28.3 million across 5 years, with a median of -$31.6 million in 2022.
- Annual changes were most pronounced in 2025 — EBT surged 372.83% — and 2026, when it plunged 218.75%.
- Century Therapeutics' EBT stood at -$31.6 million in 2022, then retreated by 27.23% to -$40.3 million in 2023, then climbed by 14.83% to -$34.3 million in 2024, then jumped by 72.16% to -$9.5 million in 2025, then slumped by 852.26% to -$90.9 million in 2026.
- Business Quant data shows IPSC's EBT at -$90.9 million in Q1 2026, -$9.5 million in Q4 2025, and -$34.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | -90.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -90.36 Mn |
| Mar 31, 2026 | -90.91 Mn |
| Dec 31, 2025 | -9.55 Mn |
| Sep 30, 2025 | -34.42 Mn |
| Jun 30, 2025 | -32.54 Mn |
| Mar 31, 2025 | 76.56 Mn |
| Dec 31, 2024 | -34.30 Mn |
| Sep 30, 2024 | -31.23 Mn |
| Jun 30, 2024 | -31.19 Mn |
| Mar 31, 2024 | -28.06 Mn |
| Dec 31, 2023 | -40.27 Mn |
| Sep 30, 2023 | -32.13 Mn |
| Jun 30, 2023 | -32.34 Mn |
| Mar 31, 2023 | -30.06 Mn |
| Dec 31, 2022 | -31.65 Mn |
| Sep 30, 2022 | -30.72 Mn |
| Jun 30, 2022 | -30.97 Mn |
| Mar 31, 2022 | -37.50 Mn |
| Dec 31, 2021 | -28.15 Mn |
| Sep 30, 2021 | -26.01 Mn |